Failure is an Option

Blogger DrugMonkey says that when it comes to NIH grants, a little failure can be a good thing. NIH/CSR review panels seem to be fixated on preliminary data, DrugMonkey says, perhaps because the reviewers think part of their job is to separate the projects that will succeed from those that will fail. But what does it mean to fail?

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.